Skip to main content

Grafa News and Videos — Page 1476

Latest

Grafa

Gilead secures final regulatory clearance for $115-per-share Arcellx acquisition

Gilead Sciences (NASDAQ:GILD) announced today that it has cleared all necessary regulatory hurdles for its multi-billion dollar acquisition of Arcellx, marking the final steps toward integrating the biotech’s advanced cell therapy platform.

Read more: Gilead secures final regulatory clearance for $115-per-share Arcellx acquisition

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift